跳至主要内容
临床试验/JPRN-jRCTs061230077
JPRN-jRCTs061230077招募中3 期

Efficacy of butyric Acid preparations in patients with unresectable hepatocellular carcinoma underGoing systEmic chemotheRapy - EAGER study

Otsuka Motoyuki0 个研究点目标入组 25 人开始时间: 2023年11月15日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • 1 18 age old over
  • 2 Regardless of gender
  • 3 Patients diagnosed with unresectable hepatocellular carcinoma
  • 4 Patients who will receive treatment with Durvalumab and Tremelimumab
  • 5 Patients who have been fully informed consent

排除标准

  • 1 Patients with Child-Pugh score over 8
  • 2 Patients used to have hypersensitivity with butyric acid
  • 3 Being pregnant or possibly pregnant
  • 4 Patients who judged as inappropriate candidate by the chief medical examine

研究者

发起方
Otsuka Motoyuki

相似试验